An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA/MSN hybrid nanoparticles.
Journal of drug targeting, cilt.32, ss.1101-1110, 2024 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 32
- Basım Tarihi: 2024
- Doi Numarası: 10.1080/1061186x.2024.2374034
- Dergi Adı: Journal of drug targeting
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, Chemical Abstracts Core, International Pharmaceutical Abstracts, MEDLINE
- Sayfa Sayıları: ss.1101-1110
- Hacettepe Üniversitesi Adresli: Evet